`
`“—
`
`——
`
`Title of Invention:
`
`DE NOVO SYNTHESIZED GENE LIBRARIES
`
`
`
`——
`
`Payment information:
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`——
`
`
`
`
`
`- a
`
`File Listing:
`
`Document
`Number
`
`Document Descri
`
`tion
`
`p
`
`File Size(Bytes)/
`Message Digest
`333217
`
`Pages
`Multi
`Part /.zip (if appl.)
`
`Twist_44854—701—304_Su pp—
`|DS_O9May2019.pdf
`
`84ac4d8f28e332f381a691b5c5c47a751d3c
`B953
`
`Transmittal Letter
`
`Foreign Reference
`
`WOZOO6023144A2.PDF
`
`d1ff3129f65fbf1891aeafac9b9df37e850cfe
`ee
`
`2974674
`
`Foreign Reference
`
`WOZOO804538OA2.PDF
`
`6219887
`
`4482786
`
`Foreign Reference
`
`W02016161244A2_EFS.PDF Sadd533d912c42018534e0067c33f80f12d '
`73c9
`
`Foreign Reference
`
`W02016173719A1_EFS.PDF 4260fc2f2ea44501dfd87d565253d8ff27b7 .
`19d
`
`9122160
`
`9'.o qE W=- oE
`
`||||||||H||||||
`
`a”.o qE W=- oE
`
`”.c: .t53 W=- c:5!
`
`- a
`
`”.c: .t53 W=- c:=!
`
`- a
`
`”.c: .t53 W=- c:E!
`
`
`
`Non Patent Literature
`
`POSAM_MAN_CH1_ASSEMBLY
`_V1—2_O40601.PDF
`
`f40650f646854c756eb4935f6e6299dedd75
`9f1c
`
`15290440
`
`Non Patent Literature
`
`EROSHENKO_2012.PDF
`
`242487
`
`5440694c24ad93f308894764630630646d4
`8de56
`
`Other Reference—Patent/App/Search
`documents
`
`213336
`
`EP148346653_FURTHER-
`EXAMINATION-
`REPORT_28NOV20‘| 8_ P DF
`
`9c51
`3f2950136385f9f8ccd3379877638d19e047
`
`Other Reference—Patent/App/Search
`documents
`
`303131
`
`EP16847497_EXTENDED-
`EUROPEAN-SEARCH-
`REPORT_09J AN 201 9_ P DF
`
`Bdea
`34eedffc2d69ed26b7d1385c5d2336b32d4
`
`.-
`
`Other Reference—Patent/App/Search
`documents
`
`PCTU52017026232—
`|PRP_26FEBZO19.PDF
`
`Other Reference—Patent/App/Search
`documents
`
`PCTU52017045105|PRP_05FEB
`2019.PDF
`
`Other Reference—Patent/App/Search
`documents
`
`PCTU52018050511_ISR—
`WO_11JAN2019.PDF
`
`556435
`
`c2042cfb04a7c74c62b8344181d9dd3726e
`7367c
`
`429871
`
`1508d801e7f14554033b0e10ad4c1af82f0
`522e
`
`914493
`
`71350bf2b2feec71b51d01885209d321f1I ‘
`4ee2
`
`
`
`Other Reference—Patent/App/Search
`documents
`
`PCTUS2019012218_|SR—
`WO_21MAR2019.PDF
`
`65431 1
`
`e1212fa9fc7c7e8f190017a9f87af54237ff0b
`db
`
`Non Patent Literature
`
`LEE_TH ESIS_2001_MIT_PART1.
`
`Non Patent Literature
`
`LEE_TH ESIS_2001_MIT_PART2.
`
`14323437
`
`8605e68eceb898e7b8dc035447ae84d91a1
`811fa
`
`12117250
`
`B440814d8fl22€24f57fl507e1 6d17e221cf5
`af7
`
`- -
`
`Non Patent Literature
`
`873616
`
`DOUTHWAITE_AFF|N|TY—
`MATURATION—
`NOVEL—01JAN2015.PDF
`
`d525305f44c3c800744c988883c02272137
`63de
`
`Non Patent Literature
`
`JO-ENGINEERING-
`THERAPEUTIC-
`4c54
`ANTI BODI ES_05 FEBZO‘I 6_ PDF 7be9656c860c293f9bfd92b9ec6c18cc87b
`
`1349845
`
`Non Patent Literature
`
`1 191292
`
`LAUSTED-POSAM-
`OLIGONUCLEOTIDE-
`SYNTH ES IZE R_2004_ PDF
`
`b143c
`878e0210e04382f2295c97b68c7d98c413c
`
`Non Patent Literature
`
`220367
`
`MARTINEZ_TARGET|NG—
`EXTRACELLULAR—
`DOMA|N_2005.PDF
`
`f9a453208c4d652940cdaf7124402cc29657
`3091
`
`
`
`Non Patent Literature
`
`PCTUSZO18037161_ISR—
`WO_220CT18.PDF
`
`e6daadd09b33857664356bf1f414bc4e058
`192bd
`
`2193477
`
`Other Reference—Patent/App/Search
`documents
`
`PCTUSZO18OS6783_ISR—
`WO_20DEC2018.PDF
`
`3b4d0343e737348f6fddfff17f9763e795e26
`bca
`
`653403
`
`Non Patent Literature
`
`US1501559_NON—F|NAL—
`OA_O7FEBZO19.PDF
`
`e4feaff946e22f0c6459db157568627fd5ce8
`e48
`
`409994
`
`Non Patent LIterature
`
`US15156134_OA_O4APR2019.
`
`081e9223300bceb3e3b307952bf129fb105
`23b4d
`
`7997343
`
`Non Patent LIterature
`
`US15268422_NFOA_O1MAR20
`19.PDF
`
`7f1627efa10f11fb4ff5305b537c97a91fc302
`79
`
`7313162
`
`71f18137d16fd8350dafiad2127a958d9396
`
`180613
`
`0198 -
`
`28e15
`
`Non Patent LIterature
`
`US15377547_F|NAL—
`OA_O8FEBZO19.PDF
`
`Non Patent LIterature
`
`US15433909_NON—F|NAL—
`OA_O8FEBZO19.PDF
`
`1986d2db7ee18070eb43d983390bc080ed ‘
`
`7655067
`
`
`
`Non Patent Literature
`
`US15602991_F|NAL_OFF|CE_A
`CTION_2018—12—13.PDF
`
`ed4b4771Cfo1faSa1755617fd5d8414fcd7 -
`70f
`
`1678570
`
`Non Patent Literature
`
`US15729564_F|NAL_OFF|CE_A
`CTION_2018—12—13.PDF
`
`4fe16c24e0df4c31bc3788bd83e5e28ef6c2
`2171
`
`1469062
`
`Non Patent Literature
`
`US15151316_F|NAL—
`OA_21FEB2019.PDF
`
`e9c68d9dbfc47e095d05696e45456f2d538
`a703b
`
`2380456
`
`Non Patent Literature
`
`US15860445_F|NAL_OFFICE_A
`CTION_2018—12—13.PDF
`
`4247d48c596e1a156bf2e5d24461bcf4041I
`
`206114
`
`1 13
`
`Non Patent Literature
`
`U515816995_RR_O4APR2019.
`
`262563
`
`eddadSeb5b941e40bc02b5edee5252dae6
`1 e01 e4
`
`1210476
`
`Non Patent Literature
`
`PCTUS1837161_WU_SEQUENC
`E—SPEC|F|C_2011.PDF
`
`aae73097846138dce37dbcbd0159e2c3c3d
`69cb6
`
`Non Patent Literature
`
`PCTUS1837161_ZHOU—
`ESTABLISHMENT_2014.PDF
`
`42ea16d4e6ecff036bf2bf3358031f31e0e2
`
`781229
`
`
`
`Information:
`
`Total Files Size (in bytes)
`
`106235281
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`Fee Worksheet (SBO6)
`
`fee—info.pdf
`
`3fb9e35187eldaBec2301f76bb3d97c44b2
`40893
`
`
`
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`